%0 Journal Article
%T Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolism.
%A Mülling N
%A Behr FM
%A Heieis GA
%A Boss K
%A van Duikeren S
%A van Haften FJ
%A Pardieck IN
%A van der Gracht ET
%A Vleeshouwers W
%A van der Sluis TC
%A de Graaf JF
%A Veerkamp DM
%A Franken KL
%A Lei X
%A van de Sand L
%A van der Burg SH
%A Welters MJ
%A Heidt S
%A Huisman W
%A Jochems SP
%A Giera M
%A Witzke O
%A de Vries AP
%A Kribben A
%A Everts B
%A Wilde B
%A Arens R
%J J Clin Invest
%V 0
%N 0
%D 2024 Jul 2
%M 38954588
%F 19.456
%R 10.1172/JCI179561
%X Cytomegalovirus (CMV) is one of the most common and relevant opportunistic pathogens in immunocompromised individuals such as kidney transplant recipients (KTRs). The exact mechanisms underlying the disability of cytotoxic T cells to provide sufficient protection against CMV in immunosuppressed individuals have not been identified yet. Here, we performed in-depth metabolic profiling of CMV-specific CD8+ T cells in immunocompromised patients and show the development of metabolic dysregulation at the transcriptional, protein, and functional level of CMV-specific CD8+ T cells in KTRs with non-controlled CMV infection. These dysregulations comprise impaired glycolysis and increased mitochondrial stress, which is associated with an intensified expression of the nicotinamide adenine dinucleotide nucleotidase (NADase) CD38. Inhibiting NADase activity of CD38 reinvigorated the metabolism and improved cytokine production of CMV-specific CD8+ T cells. These findings were corroborated in a mouse model of CMV infection under conditions of immunosuppression. Thus, dysregulated metabolic states of CD8+ T cells could be targeted by inhibiting CD38 to reverse hypo-responsiveness in individuals who fail to control chronic viral infection.